trending Market Intelligence /marketintelligence/en/news-insights/trending/a8sL0u0Js2_7Wsp0cKLGNg2 content esgSubNav
In This List

Jaguar Animal Health completes merger with Napo Pharmaceuticals

Blog

Insight Weekly: US inflation soars; real estate faces slowdown; megadeals drive tech M&A

Blog

Commercial Banking: June 22nd Edition

Blog

Understanding Loss Given Default A Review of Three Approaches

Blog

Insight Weekly: Path to net-zero; US manufacturing momentum; China's lithium M&A frenzy


Jaguar Animal Health completes merger with Napo Pharmaceuticals

Jaguar Animal Health Inc. completed its merger with Napo Pharmaceuticals Inc. and changed its name to Jaguar Health Inc.

Napo has started operating as a unit of Jaguar focused on human health and the ongoing commercialization of Mytesi, which is approved by the U.S. Food and Drug Administration for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy.

Jaguar said it will continue trading under the Nasdaq ticker symbol JAGX.